Rosuvastatin Calcium
(BPRHUIZQVSMCRT-VEUZHWNKSA-N)
Structure
- SMILES
- O[C@@H](C[C@H](CC(=O)O)O)/C=C/c1c(nc(nc1c1ccc(cc1)F)N(S(=O)(=O)C)C)C(C)C
- Type(s)
- Approved
- ATC code(s)
- A10BH52; C10AA07; C10BA06; C10BX05; C10BX07; C10BX09; C10BX10; C10BX13; C10BX14; G01AE10
- Molecular Formula:
- C22H28FN3O6S
- Molecular Weight:
- 481.538
- Log P:
- 3.4825
- Hydrogen Bond Acceptor:
- 9
- Hydrogen Bond Donor:
- 3
- TPSA:
- 149.3
- CAS Number(s):
- 147098-20-2; 287714-41-4; 1094100-06-7
Synonym(s)
1.
Rosuvastatin Calcium
2.
Crestor
3.
Rosuvastatin
4.
ZD 4522
5.
ZD4522
6.
Calcium, Rosuvastatin
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Myalgia | FAERS: 146 Canada Vigilance: 64 | Canada Vigilance SIDER US FAERS | |
| 2 | Rhabdomyolysis | FAERS: 80 Canada Vigilance: 12 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 3 | Fatigue | FAERS: 29 Canada Vigilance: 5 | Canada Vigilance OFFSIDES US FAERS | |
| 4 | Product substitution issue | FAERS: 29 Canada Vigilance: 87 | Canada Vigilance US FAERS | |
| 5 | Arthralgia | FAERS: 28 Canada Vigilance: 8 | Canada Vigilance SIDER US FAERS | |
| 6 | Dizziness | FAERS: 28 Canada Vigilance: 12 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 7 | Headache | FAERS: 21 Canada Vigilance: 9 | Canada Vigilance SIDER US FAERS | |
| 8 | Nausea | FAERS: 21 Canada Vigilance: 18 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 9 | Chromaturia | FAERS: 20 | OFFSIDES US FAERS | |
| 10 | Myasthenia Gravis | FAERS: 20 | US FAERS | |
| 11 | Myopathy | FAERS: 20 Canada Vigilance: 9 | Canada Vigilance SIDER US FAERS | |
| 12 | Alanine Aminotransferase Increased | FAERS: 19 | US FAERS | |
| 13 | Tremor | FAERS: 19 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 14 | Blood creatine phosphokinase increased | FAERS: 18 Canada Vigilance: 7 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 15 | Abdominal Pain | FAERS: 17 Canada Vigilance: 11 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 16 | Acute kidney injury | FAERS: 17 | US FAERS | |
| 17 | Aspartate Aminotransferase Increased | FAERS: 17 | US FAERS | |
| 18 | Asthenia | FAERS: 17 Canada Vigilance: 3 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 19 | Constipation | FAERS: 16 Canada Vigilance: 2 | Canada Vigilance SIDER US FAERS | |
| 20 | Back Pain | FAERS: 15 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 21 | Blood cholesterol increased | FAERS: 15 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 22 | Pruritus | FAERS: 15 Canada Vigilance: 3 | Canada Vigilance SIDER US FAERS | |
| 23 | Drug ineffective | FAERS: 14 Canada Vigilance: 14 | Canada Vigilance OFFSIDES US FAERS | |
| 24 | Pain | FAERS: 13 Canada Vigilance: 7 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 25 | Burning sensation | FAERS: 12 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 26 | Polyneuropathy | FAERS: 10 | US FAERS | |
| 27 | Vomiting | FAERS: 10 Canada Vigilance: 8 | Canada Vigilance US FAERS | |
| 28 | Musculoskeletal stiffness | FAERS: 9 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 29 | Abdominal discomfort | FAERS: 8 Canada Vigilance: 14 | Canada Vigilance OFFSIDES US FAERS | |
| 30 | Depressed mood | FAERS: 8 | US FAERS | |
| 31 | Hypersensitivity | FAERS: 8 | SIDER US FAERS | |
| 32 | Malaise | FAERS: 8 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 33 | Priapism | FAERS: 8 | US FAERS | |
| 34 | Syncope | FAERS: 8 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 35 | Chest discomfort | FAERS: 7 | US FAERS | |
| 36 | Formication | FAERS: 7 | US FAERS | |
| 37 | Limb discomfort | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 38 | Myositis | FAERS: 7 | SIDER US FAERS | |
| 39 | Oropharyngeal pain | FAERS: 7 | OFFSIDES US FAERS | |
| 40 | Restless Legs Syndrome | FAERS: 7 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 41 | Cerebrovascular accident | FAERS: 6 | US FAERS | |
| 42 | Chest Pain | FAERS: 6 Canada Vigilance: 5 | Canada Vigilance OFFSIDES US FAERS | |
| 43 | Dysgeusia | FAERS: 6 | US FAERS | |
| 44 | Gait inability | FAERS: 6 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 45 | Lip swelling | FAERS: 6 | US FAERS | |
| 46 | Musculoskeletal discomfort | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 47 | Palpitations | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 48 | Weight decreased | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 49 | Amnesia | FAERS: 5 Canada Vigilance: 2 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 50 | Autoimmune hepatitis | FAERS: 5 | OFFSIDES US FAERS | |
| 51 | Contraindicated product administered | FAERS: 5 | US FAERS | |
| 52 | Gamma-Glutamyltransferase Increased | FAERS: 5 | US FAERS | |
| 53 | Memory impairment | FAERS: 5 | SIDER US FAERS | |
| 54 | Middle insomnia | FAERS: 5 | US FAERS | |
| 55 | Night sweats | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 56 | Tension Headache | FAERS: 5 | US FAERS | |
| 57 | Therapeutic response unexpected | FAERS: 5 | US FAERS | |
| 58 | Wheelchair user | FAERS: 5 | US FAERS | |
| 59 | Wrong technique in product usage process | FAERS: 5 | US FAERS | |
| 60 | Blood creatinine increased | FAERS: 4 | OFFSIDES US FAERS | |
| 61 | Blood glucose increased | FAERS: 4 | US FAERS | |
| 62 | Blood urea increased | FAERS: 4 | OFFSIDES US FAERS | |
| 63 | Cerebral Infarction | FAERS: 4 | US FAERS | |
| 64 | Feeling abnormal | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance OFFSIDES SIDER US FAERS | |
| 65 | Hypotension | FAERS: 4 | US FAERS | |
| 66 | Low density lipoprotein increased | FAERS: 4 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 67 | Throat irritation | FAERS: 4 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 68 | Transaminases increased | FAERS: 4 | US FAERS | |
| 69 | jaundice | FAERS: 4 | SIDER US FAERS | |
| 70 | Acne | FAERS: 3 | US FAERS | |
| 71 | Anaphylactic shock | FAERS: 3 | US FAERS | |
| 72 | Anti-neutrophil cytoplasmic antibody positive vasculitis | FAERS: 3 | US FAERS | |
| 73 | Anxiety | FAERS: 3 | US FAERS | |
| 74 | Atrial Fibrillation | FAERS: 3 | US FAERS | |
| 75 | Dehydration | FAERS: 3 | OFFSIDES US FAERS | |
| 76 | Dyspepsia | FAERS: 3 Canada Vigilance: 12 | Canada Vigilance SIDER US FAERS | |
| 77 | Eczema | FAERS: 3 | US FAERS | |
| 78 | Lipoprotein (a) increased | FAERS: 3 | US FAERS | |
| 79 | Musculoskeletal Pain | FAERS: 3 | OFFSIDES US FAERS | |
| 80 | Pancreatic carcinoma | FAERS: 3 | US FAERS | |
| 81 | Polymyositis | FAERS: 3 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 82 | Stevens-Johnson Syndrome | FAERS: 3 | US FAERS | |
| 83 | Thrombocytopenia | FAERS: 3 | SIDER US FAERS | |
| 84 | Urticaria | FAERS: 3 Canada Vigilance: 7 | Canada Vigilance SIDER US FAERS | |
| 85 | Acute myocardial infarction | FAERS: 2 | US FAERS | |
| 86 | Amyotrophic Lateral Sclerosis | FAERS: 2 | US FAERS | |
| 87 | Angina Pectoris | FAERS: 2 | US FAERS | |
| 88 | Angioedema | FAERS: 2 Canada Vigilance: 3 | Canada Vigilance SIDER US FAERS | |
| 89 | Arthritis | FAERS: 2 | OFFSIDES US FAERS | |
| 90 | Arthropathy | FAERS: 2 | US FAERS | |
| 91 | Azoospermia | FAERS: 2 | US FAERS | |
| 92 | Biliary dilatation | FAERS: 2 | US FAERS | |
| 93 | Blood alkaline phosphatase increased | FAERS: 2 | US FAERS | |
| 94 | Bronchopneumonia | FAERS: 2 | US FAERS | |
| 95 | Dermatomyositis | FAERS: 2 | US FAERS | |
| 96 | Diabetes Mellitus | FAERS: 2 | SIDER US FAERS | |
| 97 | Diplopia | FAERS: 2 | US FAERS | |
| 98 | Dry skin | FAERS: 2 | US FAERS | |
| 99 | Epistaxis | FAERS: 2 | US FAERS | |
| 100 | Fibromyalgia | FAERS: 2 | US FAERS | |
| 101 | Hepatitis | FAERS: 2 | SIDER US FAERS | |
| 102 | Impaired work ability | FAERS: 2 | US FAERS | |
| 103 | Joint swelling | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 104 | Lethargy | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 105 | Mental status changes | FAERS: 2 | OFFSIDES US FAERS | |
| 106 | Metabolic acidosis | FAERS: 2 | US FAERS | |
| 107 | Myoclonus | FAERS: 2 | US FAERS | |
| 108 | Pancreatic Cyst | FAERS: 2 | US FAERS | |
| 109 | Peripheral swelling | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 110 | Polymyalgia Rheumatica | FAERS: 2 | US FAERS | |
| 111 | Product quality issue | FAERS: 2 | US FAERS | |
| 112 | Product use in unapproved indication | FAERS: 2 | US FAERS | |
| 113 | Renal tubular necrosis | FAERS: 2 | US FAERS | |
| 114 | Sepsis | FAERS: 2 | US FAERS | |
| 115 | Supraventricular tachycardia | FAERS: 2 | US FAERS | |
| 116 | Swelling | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 117 | Unevaluable event | FAERS: 2 | US FAERS | |
| 118 | Urinary Retention | FAERS: 2 | US FAERS | |
| 119 | Vasculitis | FAERS: 2 | US FAERS | |
| 120 | Abasia | FAERS: 1 | US FAERS | |
| 121 | Accidental overdose | FAERS: 1 | US FAERS | |
| 122 | Agitation | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 123 | Allergic reaction to excipient | FAERS: 1 | US FAERS | |
| 124 | Aphasia | FAERS: 1 | US FAERS | |
| 125 | Arteriosclerosis | FAERS: 1 | US FAERS | |
| 126 | Ascites | FAERS: 1 | US FAERS | |
| 127 | Asterixis | FAERS: 1 | US FAERS | |
| 128 | Asthma | FAERS: 1 | US FAERS | |
| 129 | Bladder spasm | FAERS: 1 | US FAERS | |
| 130 | Blepharospasm | FAERS: 1 | OFFSIDES US FAERS | |
| 131 | Blood alkaline phosphatase decreased | FAERS: 1 | US FAERS | |
| 132 | Blood amylase increased | FAERS: 1 | OFFSIDES US FAERS | |
| 133 | Blood lactate dehydrogenase increased | FAERS: 1 | US FAERS | |
| 134 | Blood urea nitrogen/creatinine ratio increased | FAERS: 1 | US FAERS | |
| 135 | Blood urine present | FAERS: 1 | OFFSIDES US FAERS | |
| 136 | Chills | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 137 | Cholestasis | FAERS: 1 | US FAERS | |
| 138 | Cold sweat | FAERS: 1 | US FAERS | |
| 139 | Contraindicated drug prescribed | FAERS: 1 | US FAERS | |
| 140 | Coronary Artery Disease | FAERS: 1 | US FAERS | |
| 141 | Depressed Level of Consciousness | FAERS: 1 | US FAERS | |
| 142 | Drug dose omission | FAERS: 1 | US FAERS | |
| 143 | Drug exposure during pregnancy | FAERS: 1 | US FAERS | |
| 144 | Duodenal Ulcer | FAERS: 1 | US FAERS | |
| 145 | Dysphonia | FAERS: 1 | US FAERS | |
| 146 | Enzyme level increased | FAERS: 1 | US FAERS | |
| 147 | Eosinophilia | FAERS: 1 | US FAERS | |
| 148 | Erectile dysfunction | FAERS: 1 | OFFSIDES US FAERS | |
| 149 | Eructation | FAERS: 1 | US FAERS | |
| 150 | Erythema | FAERS: 1 | OFFSIDES US FAERS | |
| 151 | Essential Hypertension | FAERS: 1 | US FAERS | |
| 152 | Essential Tremor | FAERS: 1 | US FAERS | |
| 153 | Excoriation | FAERS: 1 | US FAERS | |
| 154 | Exposure to toxic agent | FAERS: 1 | US FAERS | |
| 155 | Feeling Cold | FAERS: 1 | OFFSIDES US FAERS | |
| 156 | Feeling jittery | FAERS: 1 | US FAERS | |
| 157 | Flatulence | FAERS: 1 | SIDER US FAERS | |
| 158 | Flushing | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 159 | Gangrene | FAERS: 1 | US FAERS | |
| 160 | Gout | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 161 | Graft infection | FAERS: 1 | US FAERS | |
| 162 | Hepatic necrosis | FAERS: 1 | US FAERS | |
| 163 | Hepatitis B core antibody positive | FAERS: 1 | US FAERS | |
| 164 | Hepatitis B surface antibody positive | FAERS: 1 | US FAERS | |
| 165 | Hepatitis C | FAERS: 1 | US FAERS | |
| 166 | Hepatomegaly | FAERS: 1 | US FAERS | |
| 167 | Hypophagia | FAERS: 1 | US FAERS | |
| 168 | Hypothyroidism | FAERS: 1 | US FAERS | |
| 169 | Immobile | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 170 | Impaired driving ability | FAERS: 1 | US FAERS | |
| 171 | Incorrect dose administered | FAERS: 1 | US FAERS | |
| 172 | Increased insulin requirement | FAERS: 1 | US FAERS | |
| 173 | Infarction | FAERS: 1 | US FAERS | |
| 174 | Inflammation | FAERS: 1 | US FAERS | |
| 175 | Infrequent bowel movements | FAERS: 1 | US FAERS | |
| 176 | Initial insomnia | FAERS: 1 | US FAERS | |
| 177 | Joint Range of Motion Decreased | FAERS: 1 | US FAERS | |
| 178 | Leukocytosis | FAERS: 1 | US FAERS | |
| 179 | Lipase increased | FAERS: 1 | US FAERS | |
| 180 | Lipids abnormal | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 181 | Lobar Pneumonia | FAERS: 1 | US FAERS | |
| 182 | Low density lipoprotein abnormal | FAERS: 1 | US FAERS | |
| 183 | Monoplegia | FAERS: 1 | US FAERS | |
| 184 | Mood swings | FAERS: 1 | US FAERS | |
| 185 | Mouth swelling | FAERS: 1 | US FAERS | |
| 186 | Multiple Sclerosis | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 187 | Myoglobinuria | FAERS: 1 | SIDER US FAERS | |
| 188 | Myotonic Dystrophy | FAERS: 1 | US FAERS | |
| 189 | Neck Pain | FAERS: 1 | US FAERS | |
| 190 | Nerve Root Compression | FAERS: 1 | US FAERS | |
| 191 | Nervousness | FAERS: 1 | US FAERS | |
| 192 | Neuralgia | FAERS: 1 | US FAERS | |
| 193 | Obsessive-Compulsive Disorder | FAERS: 1 | US FAERS | |
| 194 | Oropharyngeal discomfort | FAERS: 1 | US FAERS | |
| 195 | Pancreatitis | FAERS: 1 | OFFSIDES SIDER US FAERS | |
| 196 | Paraplegia | FAERS: 1 | US FAERS | |
| 197 | Portal Hypertension | FAERS: 1 | US FAERS | |
| 198 | Presyncope | FAERS: 1 | US FAERS | |
| 199 | Product physical issue | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 200 | Product solubility abnormal | FAERS: 1 | US FAERS | |
| 201 | Product taste abnormal | FAERS: 1 | US FAERS | |
| 202 | Product use issue | FAERS: 1 | US FAERS | |
| 203 | Protein urine present | FAERS: 1 | SIDER US FAERS | |
| 204 | Quadriparesis | FAERS: 1 | US FAERS | |
| 205 | Respiratory distress | FAERS: 1 | US FAERS | |
| 206 | Retinal Detachment | FAERS: 1 | US FAERS | |
| 207 | Rosacea | FAERS: 1 | US FAERS | |
| 208 | Scab | FAERS: 1 | US FAERS | |
| 209 | Sciatica | FAERS: 1 | US FAERS | |
| 210 | Sjogren's Syndrome | FAERS: 1 | US FAERS | |
| 211 | Skin Ulcer | FAERS: 1 | US FAERS | |
| 212 | Skin nodule | FAERS: 1 | US FAERS | |
| 213 | Somnolence | FAERS: 1 | US FAERS | |
| 214 | Stress | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance OFFSIDES US FAERS | |
| 215 | Systemic Scleroderma | FAERS: 1 | US FAERS | |
| 216 | Therapeutic response unexpected with drug substitution | FAERS: 1 | US FAERS | |
| 217 | Therapy non-responder | FAERS: 1 | US FAERS | |
| 218 | Thirst | FAERS: 1 | US FAERS | |
| 219 | Urinary Incontinence | FAERS: 1 | US FAERS | |
| 220 | Vertebrobasilar Insufficiency | FAERS: 1 | US FAERS | |
| 221 | Visual disturbance | FAERS: 1 | US FAERS | |
| 222 | Wheezing | FAERS: 1 | US FAERS | |
| 223 | muscle injury | FAERS: 1 | OFFSIDES US FAERS | |
| 224 | nervous system disorder | FAERS: 1 | SIDER US FAERS | |
| 225 | treatment failure | FAERS: 1 | US FAERS | |
| 226 | Abnormal vision | OFFSIDES | ||
| 227 | Abscess | OFFSIDES | ||
| 228 | Acute glomerulonephritis | OFFSIDES | ||
| 229 | Ageusia | OFFSIDES | ||
| 230 | Alcohol consumption | OFFSIDES | ||
| 231 | Alopecia | OFFSIDES | ||
| 232 | Amyloidosis | OFFSIDES | ||
| 233 | Aneurysm | OFFSIDES | ||
| 234 | Anuria | OFFSIDES | ||
| 235 | Aortic Aneurysm | OFFSIDES | ||
| 236 | Aortic Injury | OFFSIDES | ||
| 237 | Apathy | OFFSIDES | ||
| 238 | Application site ulcer | OFFSIDES | ||
| 239 | Atrioventricular Block | Canada Vigilance: 1 | Canada Vigilance | |
| 240 | Axonal neuropathy | OFFSIDES | ||
| 241 | Benign Prostatic Hyperplasia | Canada Vigilance: 1 | Canada Vigilance | |
| 242 | Bladder prolapse | OFFSIDES | ||
| 243 | Blepharitis | OFFSIDES | ||
| 244 | Blepharoptosis | OFFSIDES | ||
| 245 | Blood chloride decreased | OFFSIDES | ||
| 246 | Blood cholesterol | OFFSIDES | ||
| 247 | Blood creatine phosphokinase abnormal | Canada Vigilance: 1 | Canada Vigilance | |
| 248 | Blood phosphorus increased | OFFSIDES | ||
| 249 | Blood potassium | OFFSIDES | ||
| 250 | Blood pressure inadequately controlled | OFFSIDES | ||
| 251 | Blood uric acid | OFFSIDES | ||
| 252 | Blurred vision | OFFSIDES | ||
| 253 | Bone density decreased | OFFSIDES | ||
| 254 | Brain natriuretic peptide increased | OFFSIDES | ||
| 255 | Breast cancer recurrent | OFFSIDES | ||
| 256 | Bronchial Obstruction | OFFSIDES | ||
| 257 | Bronchitis | Canada Vigilance: 1 | Canada Vigilance OFFSIDES SIDER | |
| 258 | CD4 Lymphocytes Decreased | OFFSIDES | ||
| 259 | Catheter placement | OFFSIDES | ||
| 260 | Catheter site infection | OFFSIDES | ||
| 261 | Cellulitis | OFFSIDES | ||
| 262 | Cerebral Arteriosclerosis | OFFSIDES | ||
| 263 | Cervicobrachial syndrome | OFFSIDES | ||
| 264 | Choking sensation | OFFSIDES | ||
| 265 | Cholecystitis | OFFSIDES | ||
| 266 | Chronic Obstructive Airway Disease | OFFSIDES | ||
| 267 | Chronic respiratory failure | OFFSIDES | ||
| 268 | Coronary angioplasty | OFFSIDES | ||
| 269 | Creatine Phosphokinase Increased | SIDER | ||
| 270 | Deafness Neurosensory | OFFSIDES | ||
| 271 | Delayed sleep phase | OFFSIDES | ||
| 272 | Dental abscess | OFFSIDES | ||
| 273 | Dermatitis | SIDER | ||
| 274 | Device breakage | OFFSIDES | ||
| 275 | Device occlusion | OFFSIDES | ||
| 276 | Diabetes mellitus inadequate control | OFFSIDES | ||
| 277 | Diabetic Retinopathy | OFFSIDES | ||
| 278 | Discomfort | Canada Vigilance: 1 | Canada Vigilance | |
| 279 | Diverticulum | OFFSIDES | ||
| 280 | Drug level increased | Canada Vigilance: 11 | Canada Vigilance | |
| 281 | Drug withdrawal headache | OFFSIDES | ||
| 282 | Dyschezia | OFFSIDES | ||
| 283 | Dysphemia | OFFSIDES | ||
| 284 | Dysuria | Canada Vigilance: 2 | Canada Vigilance OFFSIDES | |
| 285 | Ejection Fraction Decreased | OFFSIDES | ||
| 286 | Endotoxic shock | OFFSIDES | ||
| 287 | Epidural lipomatosis | OFFSIDES | ||
| 288 | Eye inflammation | OFFSIDES | ||
| 289 | Eye pain | OFFSIDES | ||
| 290 | Eyelid Function Disorder | OFFSIDES | ||
| 291 | Gastroenteritis | SIDER | ||
| 292 | Gastrointestinal Pain | SIDER | ||
| 293 | Gastrointestinal motility disorder | OFFSIDES | ||
| 294 | Gene Mutation | Canada Vigilance: 11 | Canada Vigilance | |
| 295 | Gingival discomfort | Canada Vigilance: 1 | Canada Vigilance | |
| 296 | Gingival erythema | OFFSIDES | ||
| 297 | Globulinuria | OFFSIDES | ||
| 298 | Hearing aid user | OFFSIDES | ||
| 299 | Hemiparesis | OFFSIDES | ||
| 300 | Hyperpigmentation | OFFSIDES | ||
| 301 | Hypoaesthesia facial | OFFSIDES | ||
| 302 | Impetigo | OFFSIDES | ||
| 303 | Incoherent | OFFSIDES | ||
| 304 | Infection | SIDER | ||
| 305 | Influenza | SIDER | ||
| 306 | Infusion site mobility decreased | OFFSIDES | ||
| 307 | Intestinal Obstruction | OFFSIDES | ||
| 308 | Lipase | OFFSIDES | ||
| 309 | Lipodystrophy acquired | OFFSIDES | ||
| 310 | Livedo Reticularis | OFFSIDES | ||
| 311 | Loose tooth | OFFSIDES | ||
| 312 | Loss of visual contrast sensitivity | OFFSIDES | ||
| 313 | Malignant neoplasm progression | OFFSIDES | ||
| 314 | Mastication disorder | OFFSIDES | ||
| 315 | Medial Tibial Stress Syndrome | Canada Vigilance: 1 | Canada Vigilance | |
| 316 | Medical device complication | OFFSIDES | ||
| 317 | Memory Loss | SIDER | ||
| 318 | Meningioma | OFFSIDES | ||
| 319 | Microscopic hematuria | SIDER | ||
| 320 | Muscle Weakness | OFFSIDES | ||
| 321 | Muscular Dystrophy | OFFSIDES | ||
| 322 | Musculoskeletal chest pain | OFFSIDES | ||
| 323 | Myoglobin urine present | SIDER | ||
| 324 | Nephrogenic Fibrosing Dermopathy | OFFSIDES | ||
| 325 | Nephrotic Syndrome | OFFSIDES | ||
| 326 | Nocturia | Canada Vigilance: 1 | Canada Vigilance | |
| 327 | Nutritional condition abnormal | OFFSIDES | ||
| 328 | Ocular icterus | OFFSIDES | ||
| 329 | Onychoclasis | OFFSIDES | ||
| 330 | Oral Cavity Fistula | OFFSIDES | ||
| 331 | Oropharyngeal blistering | OFFSIDES | ||
| 332 | Oxygen saturation abnormal | OFFSIDES | ||
| 333 | Palmar erythema | OFFSIDES | ||
| 334 | Patellofemoral Pain Syndrome | OFFSIDES | ||
| 335 | Pharyngeal swelling | Canada Vigilance: 1 | Canada Vigilance | |
| 336 | Pharyngitis | SIDER | ||
| 337 | Pneumoconiosis | OFFSIDES | ||
| 338 | Pneumonia | Canada Vigilance: 1 | Canada Vigilance | |
| 339 | Polyuria | OFFSIDES | ||
| 340 | Poor quality sleep | Canada Vigilance: 1 | Canada Vigilance | |
| 341 | Posturing | OFFSIDES | ||
| 342 | Primary sequestrum | OFFSIDES | ||
| 343 | Procedural hypotension | OFFSIDES | ||
| 344 | Productive Cough | OFFSIDES | ||
| 345 | Protein total decreased | OFFSIDES | ||
| 346 | Protein-losing gastroenteropathy | OFFSIDES | ||
| 347 | Proteinuria | SIDER | ||
| 348 | Pterygium | OFFSIDES | ||
| 349 | Pulmonary radiation injury | OFFSIDES | ||
| 350 | Purulent discharge | OFFSIDES | ||
| 351 | Reaction to excipient | Canada Vigilance: 1 | Canada Vigilance | |
| 352 | Rectal discharge | OFFSIDES | ||
| 353 | Retinal Vasculitis | OFFSIDES | ||
| 354 | Rhinitis | OFFSIDES SIDER | ||
| 355 | Rhinorrhea | OFFSIDES | ||
| 356 | Rhonchi | OFFSIDES | ||
| 357 | Scotoma | OFFSIDES | ||
| 358 | Sick Sinus Syndrome | OFFSIDES | ||
| 359 | Sinusitis | Canada Vigilance: 1 | Canada Vigilance SIDER | |
| 360 | Skin Induration | OFFSIDES | ||
| 361 | Skin hypertrophy | OFFSIDES | ||
| 362 | Sleep disorder due to general medical condition, insomnia type | Canada Vigilance: 1 | Canada Vigilance | |
| 363 | Spinal column stenosis | OFFSIDES | ||
| 364 | Subcutaneous Abscess | OFFSIDES | ||
| 365 | Therapeutic response changed | Canada Vigilance: 1 | Canada Vigilance | |
| 366 | Tooth Extraction | OFFSIDES | ||
| 367 | Urinary tract infection | SIDER | ||
| 368 | Urine flow decreased | OFFSIDES | ||
| 369 | Ventricular Fibrillation | OFFSIDES | ||
| 370 | Vertigo | Canada Vigilance: 1 | Canada Vigilance | |
| 371 | Weight Gain | OFFSIDES | ||
| 372 | Wound infection staphylococcal | OFFSIDES | ||
| 373 | Xerosis | OFFSIDES |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.